The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device

N/AUnknownNCT05445115

JSP Innovations111 enrolled

Overview

Study to evaluate the use of a medical device in relieving collision dyspareunia

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

111

Conditions

Dyspareunia

Interventions

Mollie deviceDEVICE

medical device

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Females 18 years of age and older with a diagnosis of collision dyspareunia - Exclusion Criteria: \-

Locations (1)

Vero Clinics

Decatur, Illinois, United States

RECRUITING

Outcomes

Primary Outcomes

Dyspareunia Alleviation

The Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v.4.0, Change from Baseline in Pain Scores on the Visual Analog Scale at 13 Weeks

Time frame: 12 weeks

Central Contacts

Leigh Ann Grossman

CONTACT

217-615-1144 leighann176@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.